Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Marko Bukur

Trauma Surgery New York, NY Medical Doctor

NPI 1740458173 CMS profile 896977

462 1St Ave, Bellevue Hospital Center Nbv 15 S 14, New York, NY 10016

Open in the dashboard

General payments

$21,511

70 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Marko Bukur of New York, NY is reported in the CMS Open Payments database as having received $21,511 across 70 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Trauma Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $716 11
2024 General $270 4
2023 General $1,573 9
2022 General $128 2
2021 General $5,033 12
2020 General $12,615 19
2019 General $1,176 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Marko Bukur
  • Trauma Surgery median
  • Middle half of Trauma Surgery
  • National median

In program year 2025, general payments to Marko Bukur were reported at $716. Among 762 Trauma Surgery profiles paid that year, the median was $280 and the middle half received between $87 and $1,585.

Show as a table
Year Marko Bukur Trauma Surgery median Middle half National median
2019 $1,176 $153 $56–$644 $163
2020 $12,615 $123 $39–$342 $114
2021 $5,033 $142 $45–$556 $132
2022 $128 $172 $59–$732 $149
2023 $1,573 $213 $83–$1,200 $160
2024 $270 $237 $86–$1,280 $164
2025 $716 $280 $87–$1,585 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $19,895 45 payments
  2. PolyNovo North America LLC $392 5 payments
  3. Prytime Medical Devices, Inc. $201 1 payment
  4. Integra LifeSciences Corporation $190 2 payments
  5. TELA Bio, Inc. $152 2 payments
  6. Acell, Inc. $149 3 payments
  7. Atricure, Inc. $148 2 payments
  8. Allergan Inc. $72 2 payments
  9. MY01 Inc. $67 1 payment
  10. Avita Medical Americas, LLC $65 2 payments
  11. Other $179 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $16,921 16 payments
  2. Food and Beverage $2,710 41 payments
  3. Travel and Lodging $1,880 13 payments
Products named General payments · program years 2019–2025
  1. RibFix Advantage CMF & Thoracic $11,546 8 payments
  2. RibFix Blu CMF & Thoracic $9,260 13 payments
  3. RibFix Advantage CMF & Thoracic $4,762 8 payments
  4. RIBFIX BLU ADVANTAGE $1,014 4 payments
  5. AdvantageRib $985 7 payments
  6. RibFix Blu CMF & Thoracic $506 3 payments
  7. NOVOSORB BTM $349 4 payments
  8. CMF & Thoracic Product Portfolio $294 3 payments
  9. ER-REBOA $201 1 payment
  10. INTEGRA DERMAL REGENERATION TEMPLATE $190 2 payments
  11. Other $1,896 29 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

70 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Trauma Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record